Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
389.27
481.78
345.13
426.48
498.86
508.56
393.19
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
389.27
481.78
345.13
426.48
498.86
508.56
393.19
Raw Material Cost
85.15
82.00
69.40
112.42
102.89
96.36
86.90
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
1.18
0.10
0.16
0.32
0.32
1.31
Selling and Distribution Expenses
159.22
265.87
206.99
240.59
274.85
309.53
282.74
Other Expenses
11.86
2.29
3.91
2.04
2.84
5.60
0.73
Total Expenditure (Excl Depreciation)
362.99
371.96
315.54
373.57
406.43
462.16
378.22
Operating Profit (PBDIT) excl Other Income
26.299999999999997
109.80000000000001
29.6
52.9
92.4
46.4
15
Other Income
9.09
7.99
11.64
17.47
11.59
9.71
19.85
Operating Profit (PBDIT)
65.25
144.12
71.27
97.35
127.30
80.75
48.01
Interest
0.00
1.18
0.10
0.16
0.32
0.32
1.31
Exceptional Items
3.98
4.10
3.09
3.73
3.38
4.42
2.59
Gross Profit (PBDT)
304.12
399.78
275.73
314.06
395.97
412.20
306.29
Depreciation
33.44
33.44
34.64
34.64
32.35
32.35
23.11
Profit Before Tax
35.79
113.59
39.61
66.28
98.01
52.50
26.18
Tax
5.98
8.92
32.42
3.90
2.32
0.75
8.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
36.16
84.47
13.29
63.33
105.26
54.73
33.28
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
36.16
84.47
13.29
63.33
105.26
54.73
33.28
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-7.20
19.42
-7.21
-3.10
-8.87
-3.70
-14.49
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
28.96
103.88
6.07
60.22
96.39
51.03
18.79
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,224.67
3,300.91
3,215.40
3,204.83
3,138.60
3,145.02
3,062.65
Earnings per share (EPS)
0.04
0.09
0.01
0.07
0.11
0.06
0.04
Diluted Earnings per share
0.04
0.09
0.01
0.07
0.11
0.06
0.04
Operating Profit Margin (Excl OI)
5.84%
21.31%
7.24%
10.61%
16.71%
7.61%
1.28%
Gross Profit Margin
17.78%
30.52%
21.52%
23.66%
26.13%
16.68%
12.54%
PAT Margin
9.29%
17.53%
3.85%
14.85%
21.1%
10.76%
8.46%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is -19.20% vs 39.61% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -72.09% vs 1,603.28% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is -58.71% vs 128.36% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is -100.00% vs 1,100.00% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
Compare Quarterly Results Of Beijing Aosaikang Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
389.27
0
389.27
Other Operating Income
0.00
0.00
0.00
Total Operating income
389.27
0
389.27
Raw Material Cost
85.15
0
85.15
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
159.22
0
159.22
Other Expenses
11.86
0.00
11.86
Total Expenditure (Excl Depreciation)
362.99
0
362.99
Operating Profit (PBDIT) excl Other Income
26.28
0.00
26.28
Other Income
9.09
0
9.09
Operating Profit (PBDIT)
65.25
0
65.25
Interest
0.00
0
0.00
Exceptional Items
3.98
0
3.98
Gross Profit (PBDT)
304.12
0
304.12
Depreciation
33.44
0
33.44
Profit Before Tax
35.79
0
35.79
Tax
5.98
0
5.98
Provisions and contingencies
0
0
0.00
Profit After Tax
36.16
0
36.16
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
36.16
0
36.16
Share in Profit of Associates
0
0
0.00
Minority Interest
-7.20
0
-7.20
Other related items
0.00
0.00
0.00
Consolidated Net Profit
28.96
0
28.96
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,224.67
0
3,224.67
Earnings per share (EPS)
0.04
0
0.04
Diluted Earnings per share
0.04
0
0.04
Operating Profit Margin (Excl OI)
5.84%
0%
0.00
5.84%
Gross Profit Margin
17.78%
0%
0.00
17.78%
PAT Margin
9.29%
0%
0.00
9.29%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 38.93 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -19.20% vs 39.61% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -21.97% vs 6.51% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.90 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -72.09% vs 1,603.28% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -69.92% vs 153.02% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.62 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -58.71% vs 128.36% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -51.43% vs 153.73% in Jun 2025
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.84%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
